Objective: Diabetes mellitus (DM) is associated with peripheral arterial disease (PAD) and leads to worse clinical outcome compared with patients without DM. The objective of this study was to determine the impact of DM on iliofemoral artery plaque characteristics and to examine secondary clinical outcomes in patients with DM and PAD undergoing surgical revascularization.
The prevalence of diabetes mellitus (DM) is increasing across the world. 1 DM is a known risk factor for atherosclerosis and thus for peripheral arterial disease (PAD). 2 The ways in which DM influences vascular disease are multifold. DM is associated with increased inflammatory activity and endothelial cell activation, causing constrictive remodeling. [3] [4] [5] Moreover, DM causes hypercoagulability, which plays a role in plaque growth and plaque rupture and increases the risk of sudden intravascular occlusion or thrombosis. 6 Patients with DM and PAD have a more than twofold higher risk of cardiovascular morbidity and mortality compared with DM patients without PAD. 7, 8 In addition, the duration of DM is associated with higher prevalence of PAD. 9 As the prevalence of DM is expanding dramatically and the disease occurs at an increasingly younger age, 10 the number of patients with DM affected by PAD in later life will rise, consequently increasing the financial burden on health care systems worldwide. 3, 11 Plaque characteristics of patients with DM have previously been histologically examined, predominantly in carotid and coronary arteries, but conflicting results have been obtained, presumably because of the small numbers of patients. 3 A large study performed in carotid patients suffering from DM showed no difference in plaque characterization between patients with and without DM. 12 Imaging of plaques in PAD patients revealed that DM-induced atherosclerosis is mainly located in below-the-knee arteries instead of the iliofemoral segments. 13, 14 Furthermore, it is associated with calcification of the medial layer instead of the intimal layer of the arteries, known as Mönckeberg sclerosis. 15, 16 Histologic characteristics of peripheral plaques have, to our knowledge, never been investigated in a large cohort of PAD patients with DM, a prevalent comorbidity. Moreover, it is unclear whether DM is an independent and causative predictor for secondary cardiovascular disease or decreased patency rates in PAD patients undergoing surgical revascularization. 5, [17] [18] [19] [20] For this study, we analyzed a large cohort of patients undergoing plaque removal from the iliofemoral arteries to determine the impact of DM on plaque characteristics. In addition, the clinical outcome in patients with DM and PAD after endarterectomy was assessed. We hypothesized that plaque composition of iliofemoral arteries in patients with DM would be different compared with patients without DM and that patients with DM would have worse clinical outcomes and an increased need for target vessel revascularization (TVR).
METHODS
Patient population. The Athero-Express biobank is a prospective ongoing biobank study that includes blood and plaque specimens of patients undergoing carotid or iliofemoral endarterectomy surgery in two large tertiary referral hospitals in the Netherlands: the St. Antonius Hospital in Nieuwegein and the University Medical Center in Utrecht. 21 Plaque removal is conducted according to local and international guidelines, by either direct thromboendarterectomy or remote endarterectomy. 22 The use of a patch was at the clinician's discretion. Clinical data were prospectively collected from patient files and standardized questionnaires. For this study, the first entry of iliac and femoral endarterectomy for each unique patient was included, without any exclusion criteria. This enabled us to investigate the effect of one of the most prevalent comorbidities in PAD on plaque histology and to compare this with existing literature on other plaque domains, such as carotid and coronary plaques.
Presence of DM was defined as presence of one of the following: (1) DM in medical history extracted from the patient file, (2) use of either insulin or oral glucose inhibitors extracted from the patient file, or (3) self-reported DM in the patient questionnaire. Duration of the disease was extracted from the patient questionnaire. A restenotic artery at baseline was defined as surgery on an artery already treated in the past, either by percutaneous intervention or by surgery.
Follow-up data during a 3-year period were obtained through questionnaires sent to patients. Secondary cardiovascular events were validated using health records kept by general practitioners. Composite secondary cardiovascular events were defined as myocardial infarction (MI), stroke, cardiovascular death, or peripheral intervention. Cardiovascular death was defined as one of the following: fatal MI, fatal stroke (either bleeding or ischemic), fatal ruptured abdominal aneurysm, fatal heart failure, or sudden death. Stroke was defined as neurologic symptoms lasting >24 hours and diagnosed by a neurologist as a stroke. A history of coronary artery disease was defined as either one of the following: MI or percutaneous coronary intervention or coronary artery bypass graft surgery. Peripheral interventions consisted of either surgery or percutaneous events, including thrombolysis, in any artery other than the coronary arteries or the aorta. Patients could have had more than one event, but only the first occurrence of any of the secondary end points was used for the survival analyses on composite end points. To determine a measure of patency, TVR was defined during a 3-year follow-up as peripheral reintervention on the same operation side and artery as in the entry surgery. If patients suffered from more than one TVR, the first was used as an end point for the survival analysis of TVR-free survival.
The study was approved by the respective medical ethics boards of both hospitals. The study was conducted in accordance with the declaration of Helsinki. All patients provided written informed consent before participation in this study.
Sample collection. A detailed description of the sample collection within the Athero-Express biobank can be found elsewhere. 21 In short, blood is collected preoperatively from the radial artery and subsequently stored at À80 . The plaque is processed immediately after surgical removal. The culprit lesion is identified, stored in 4% formaldehyde, decalcified (softening the calcification in the plaque for handling purposes without fully dissolving it), and embedded in paraffin for histologic analysis. The rest of the plaque is cut into pieces of 5 mm and stored at À80 .
Histologic assessment. The transverse cross sections of plaque are used for histologic assessment. 23 Plaque specimens were stained for macrophages (CD68), smooth muscle cells (a-actin), collagen (picrosirius red), extent of calcification (hematoxylin-eosin), and microvessels (CD34). The presence of plaque thrombosis was determined using a combination of luminal thrombi, intraplaque hemorrhage, hematoxylin-eosin staining, and presence of fibrin by Mallory phosphotungstic acidhematoxylin staining. The presence of luminal thrombosis, intraplaque hemorrhage, or both was considered positive plaque thrombosis. Computerized analyses were used to quantify macrophages and smooth muscle cells as percentage of plaque area. Microvessels were counted in three hotspots after morphologic identification and averaged per slide. 24 Collagen and calcification were scored semiquantitatively into no, minor, moderate, or heavy staining at 40Â magnification. These categories were grouped into bins (no/minor and moderate/heavy) for the present analyses, in which no/minor represents absent staining or staining with a few clustered cells and moderate/heavy represents larger areas of positive staining. The size of the lipid core was assessed using polarized light and cut off at an area of 10% of the plaque. Digital image microscopy (AnalySiS version 3.2; Soft Imaging GmbH, Munster, Germany) was used for quantitative plaque characteristics and for determination of plaque area by tracing the internal elastic lamina as described before. 25 All histologic slides were assessed by the same blinded technician.
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Statistical analysis. Baseline characteristics were compared between patients with and without DM using Mann-Whitney U tests for non-normally distributed continuous variables and c 2 tests for categorical variables. The data were imputed using single imputation. All variables with a P value < .1 were considered possible confounders for the association between DM and plaque characteristics or outcome. Possible confounders were univariably tested against plaque characteristics or outcome, and if an association was found (cutoff point P < .1), the variable was added to the final model of the association between DM and plaque characteristics or outcome. If, in the univariable analysis, a possible confounder had been identified with any of the plaque characteristics, it was added to the final models of the association between DM and plaque characteristics. Possible confounders that were identified were body mass index, hypercholesterolemia, current smoking, hypertension, history of coronary artery disease, total cholesterol levels, low-density lipoprotein cholesterol levels, and statin use. If, in the univariable analysis, a possible confounder was significantly associated with the composite end point, it was added to the final model of the association between DM and outcome. Possible confounders determined this way were hypercholesterolemia, history of coronary artery disease, previous leg amputation, Fontaine classification, and statin use. We used logistic regression models to determine the difference between patients with and without DM on different binary plaque characteristics. Linear models were used to determine this difference between logtransformed continuous plaque characteristics. A Cox proportional hazards model was used to determine the difference between patients with and without DM on composite cardiovascular events and TVR during 3-year follow-up. Kaplan-Meier survival estimates were used for the analyses of the effect of DM in subgroups, in which strata were compared with log-rank tests. Values with a P < .05 were considered statistically significant. Single imputation was carried out with the R computing platform, version 3.0.2. All other analyses were carried out in SPSS version 21.0 (IBM Corp, Armonk, NY).
RESULTS
Baseline characteristics. A total of 651 patients were included in this study, of whom 198 (30.4%) were diagnosed with DM at the time of inclusion. Of these patients with DM, 64 (32.3%) were using insulin. Cardiovascular risk factors such as high body mass index, high blood pressure, and self-reported hypercholesterolemia were more prevalent in DM patients. Patients with DM smoked less and were more often treated with statins, probably as a consequence of secondary prevention strategies, resulting in lower cholesterol levels compared with the patients without DM. Patients with DM presented with longer duration of PAD symptoms and had a more severe clinical indication for surgery, including tissue loss (34.1% vs 16%) and rest pain (26.3% vs 21.6%), between patients with and without DM, respectively. Patients with DM more often had a history of vascular events, including (partial) amputation of the contralateral leg. All patient characteristics are shown in Table I .
Plaque phenotype. To determine the impact of DM on peripheral plaque phenotypes, seven plaque phenotypes were compared between patients with and without DM (Supplementary Table, online only). After correction for possible confounders using a multivariable logistic regression model, patients with DM had significantly more calcification in their plaques compared with patients without DM (odds ratio, 2.11; 95% confidence interval [CI], 1.43-3.12; P < .01; Supplementary Fig 1, online  only) . No other histologic plaque characteristic differed significantly between the two groups (Table II) .
Clinical outcomes. To assess whether DM influences clinical outcome in patients with PAD, the incidence of composite secondary cardiovascular outcome rate during 3-year follow-up was analyzed. Three-year follow-up information was available on 635 of 651 (97.5%) patients (Table III; Supplementary Fig 2, Supplementary Fig 3, online only).
Effect of restenosis.
As restenotic plaques show significantly different histologic features, 26 ,27 a subanalysis on Supplementary Fig 4, online only) .
Effect of duration of DM. Most detrimental vascular effects of DM arise after years of exposure to hyperglycemia, and we hypothesized that an association might exist between length of suffering from DM before surgery and plaque characteristics. Within the cohort of patients with DM (n ¼ 198), data of duration of DM were available in 130 patients (66%). No association was observed between the severity of calcification of the plaque and duration of DM (median of 10 years [interquartile range, 5.25-15] vs median of 8 years [interquartile range, 3.5-15.5] for no/minor vs moderate/heavy calcification, respectively; Supplementary Fig 5, online only) .
Moreover, when stratified on the median of years of suffering from DM (9.5 years), no association was found of longer duration of DM with composite event-free survival (mean survival time estimate, 1.9 [95% CI, 1.6-2.1] vs 1.7 [1.4-2.0] for DM diagnosis >9.5 years ago vs #9.5 years ago, respectively; log-rank test, P ¼ .57; Supplementary Fig 6, online only) .
DISCUSSION
In 651 consecutive iliac and femoral endarterectomy patients, significantly more calcification in the atherosclerotic plaque was found (odds ratio, 2.11; 95% CI, 1.43-3.12; P < .01) and a higher occurrence of secondary Although one might expect a relation between duration of symptoms and plaque calcification as a measure of plaque maturation, this association was not observed in our data. Patients with DM had longer duration of symptoms than patients without DM, but this was not associated with increased calcification. Neither did we observe an association of duration of DM with plaque calcification. This might implicate that exposure time to hyperglycemia does not increase calcification burden in plaques of DM patients operated on for PAD. These findings resemble imaging studies of patients with DM that also showed a more calcified plaque in PAD lesions.
14,16 However, not all imaging studies found this association. 28 Calcification may lead to thrombotic events in patients already suffering from hypercoagulability. 3, 6, 29 Although previous analyses showed no effect of increased calcification on secondary clinical outcomes in carotid arteries, 24 further research into the effect of plaque characteristics on secondary clinical outcome is needed in PAD patients. When we compare our plaque findings with earlier published histologic plaque analyses in different arteries, striking differences can be noted. In a large cohort (n ¼ 1455) of our own Athero-Express biobank, no differences were found in carotid endarterectomy plaques between patients with and without DM. 12 This difference could very well be due to the late-stage intervention in iliofemoral artery stenosis, in which patients first undergo walking exercise and gradual remodeling of an unstable into a stable fibrous lesion is more likely to occur. These late-stage interventions are in sharp contrast with carotid surgery, which is increasingly executed within days to weeks after a cerebrovascular event. Likewise, we were not able to replicate the larger necrotic core and increased inflammation previously found in coronary plaques from sudden cardiac death patients, although these plaques are also derived from acute events, which might also reflect a different stage of remodeling. 5, 30, 31 Clinical outcome was worse in the patients with DM, including a total of 10.7% cardiovascular deaths in 3 years, in accordance with current literature. 9 A threefold increase in leg amputation was observed in patients with DM within 3 years of initial inclusion (12.2% vs 4.3%), although literature reported even higher amputation rates of up to 30%.
9 Surprisingly, no difference was seen in MI or stroke. This could be a reflection of the overall poor 3-year prognosis of the whole cohort, independent of DM. Another possibility is that secondary prevention programs in patients with DM lead to prevention of more acute disease in the macrovasculature. One could speculate that such programs are less able to prevent peripheral microvascular alterations seen in patients with DM, which is reflected by high rates of peripheral interventions and high amputation rates observed within this cohort. Another explanation for the higher amputation rates could be decreased sensitivity toward lower limb wound or ulcers as a result of diabetic neuropathy. 4, 8 Moreover, DM is known to lead to constrictive plaque remodeling.
3 Surprisingly, comparison of TVR between patients with and without DM operated on for iliofemoral disease showed no increased risk of restenotic lesions in patients with DM who require reintervention. This indicates that other secondary events account for the significantly higher composite cardiovascular events in patients with DM. A previous analysis in our cohort showed that patients with a larger plaque area on histologic examination are more prone to secondary cardiovascular events. 25 Plaque area as a potential confounding factor in the relationship of DM and secondary outcome was examined, but no evidence for any association was found. This study has some limitations. First, all patients underwent surgical therapy for PAD, which is most often preceded by a period of optimal conservative therapy. We are therefore most likely observing the remodeling phase of the peripheral plaque and cannot make any statements about plaque initiation. In fact, this study still observes large differences between DM and non-DM patients, maybe even pointing out that a more calcified plaque in patients with DM is a mere reflection of disturbed plaque remodeling due to endothelial dysfunction in this group of patients. 8, 9 This mechanism could also be the explanation of the absence of DM-specific characteristics in plaques derived from semiacutely operated on patients with carotid artery disease. 3 Second, TVR was used as a proxy for patency rates, which is normally used to measure durability of vascular reconstruction. Unfortunately, the current study protocol and ethical approval allow only prospective data collection of events during follow-up with the use of questionnaires. Furthermore, as the University Medical Center Utrecht and the St. Antonius Hospital Nieuwegein are tertiary referral centers, many of the patients return to their peripheral hospital after the surgery for postoperative follow-up. As a result, no systematic duplex ultrasound follow-up for our patients is available, and patency, including patency rates, is difficult to define in this cohort. The use of TVR could be an incomplete measure. Therefore, our results might underestimate restenosis. However, this effect is most likely equally divided between patients with and without DM. Similarly, data regarding concomitant endovascular procedures, which could have a positive effect on the number of secondary peripheral procedures, were not available in the AtheroExpress biobank study, so we were not able to correct for this effect. Yet, we do not think this effect differs between patients with and without DM and therefore cannot confound the observed effect. Furthermore, the Athero-Express biobank study unfortunately does not contain information about the type of DM from which patients suffer. This prohibits us from making any claims as to what extent patients with type 1 DM differ from patients with type 2 DM. In addition, arteries below the knee were not covered by our biobank as these are treated either conservatively or with percutaneous or endovascular procedures. The large effect of DM on below-the-knee arteries could explain the increased rate of leg amputations. 4, 11 Next, the Athero-Express biobank study does not collect information about previous radiation therapy for pelvic or inguinal malignant neoplasms. Although we think the occurrence of these therapies is evenly distributed between patients with and without DM, patients with DM have a higher chance for development of malignant disease, and as radiation therapy gives rise to arterial occlusive disease, this could have confounded the relationship between more DM and a more calcified plaque. Last, although our biobank has been collecting plaque material since 2002, the number of 198 patients with DM remains modest. Still, our analysis holds, as far as we know, of the first comparison of plaque characterization in a cohort of patients undergoing iliofemoral endarterectomy. As the search for modifiable causative predictors of secondary cardiovascular outcome is ongoing, we would encourage other researchers to analyze large groups of patients with a variety of cardiovascular risk factors and to collect longterm follow-up. Overall, patients with DM presenting with PAD requiring surgical revascularization belong to a vulnerable subgroup of an already threatened group of patients. PAD patients often present with multiple other comorbidities and often do not achieve as adequate risk factor control as other (cardiovascular) patients do. 32 We observed more secondary cardiovascular events during follow-up in the patients with DM and PAD, which leads to increased disease burden. Therefore, these patients need to be under tight surveillance to optimize disease control and (early) treatment of possible comorbidities.
3,8

CONCLUSIONS
Patients with DM who undergo surgical revascularization for PAD with the use of thromboendarterectomy or remote endarterectomy have a more calcified atherosclerotic plaque and an increased incidence in composite cardiovascular events but no increase in TVR.
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